Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN - PubMed (original) (raw)

Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN

J P Rouault et al. Curr Biol. 1999.

Free article

Abstract

The tumour suppressor gene PTEN (also called MMAC1 or TEP1) is somatically mutated in a variety of cancer types [1] [2] [3] [4]. In addition, germline mutation of PTEN is responsible for two dominantly inherited, related cancer syndromes called Cowden disease and Bannayan-Ruvalcaba-Riley syndrome [4]. PTEN encodes a dual-specificity phosphatase that inhibits cell spreading and migration partly by inhibiting integrin-mediated signalling [5] [6] [7]. Furthermore, PTEN regulates the levels of phosphatidylinositol 3,4,5-trisphosphate (PIP3) by specifically dephosphorylating position 3 on the inositol ring [8]. We report here that the dauer formation gene daf-18 is the Caenorhabditis elegans homologue of PTEN. DAF-18 is a component of the insulin-like signalling pathway controlling entry into diapause and adult longevity that is regulated by the DAF-2 receptor tyrosine kinase and the AGE-1 PI 3-kinase [9]. Others have shown that mutation of daf-18 suppresses the life extension and constitutive dauer formation associated with daf-2 or age-1 mutants. Similarly, we show that inactivation of daf-18 by RNA-mediated interference mimics this suppression, and that a wild-type daf-18 transgene rescues the dauer defect. These results indicate that PTEN/daf-18 antagonizes the DAF-2-AGE-1 pathway, perhaps by catalyzing dephosphorylation of the PIP3 generated by AGE-1. These data further support the notion that mutations of PTEN contribute to the development of human neoplasia through an aberrant activation of the PI 3-kinase signalling cascade.

PubMed Disclaimer

Similar articles

• The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway.
  Ogg S, Ruvkun G. Ogg S, et al. Mol Cell. 1998 Dec;2(6):887-93. doi: 10.1016/s1097-2765(00)80303-2. Mol Cell. 1998. PMID: 9885576
• The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway.
  Mihaylova VT, Borland CZ, Manjarrez L, Stern MJ, Sun H. Mihaylova VT, et al. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7427-32. doi: 10.1073/pnas.96.13.7427. Proc Natl Acad Sci U S A. 1999. PMID: 10377431 Free PMC article.
• The human tumour suppressor PTEN regulates longevity and dauer formation in Caenorhabditis elegans.
  Solari F, Bourbon-Piffaut A, Masse I, Payrastre B, Chan AM, Billaud M. Solari F, et al. Oncogene. 2005 Jan 6;24(1):20-7. doi: 10.1038/sj.onc.1207978. Oncogene. 2005. PMID: 15637588
• PTEN and myotubularin: novel phosphoinositide phosphatases.
  Maehama T, Taylor GS, Dixon JE. Maehama T, et al. Annu Rev Biochem. 2001;70:247-79. doi: 10.1146/annurev.biochem.70.1.247. Annu Rev Biochem. 2001. PMID: 11395408 Review.
• Molecular genetics of life span in C. elegans: how much does it teach us?
  Hekimi S, Lakowski B, Barnes TM, Ewbank JJ. Hekimi S, et al. Trends Genet. 1998 Jan;14(1):14-20. doi: 10.1016/S0168-9525(97)01299-7. Trends Genet. 1998. PMID: 9448461 Review.

Cited by

• Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected].
  Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ, Sherwin R, Devaskar S, Lesche R, Magnuson MA, Wu H. Stiles B, et al. Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2082-7. doi: 10.1073/pnas.0308617100. Epub 2004 Feb 9. Proc Natl Acad Sci U S A. 2004. PMID: 14769918 Free PMC article.
• Suppressors of transforming growth factor-beta pathway mutants in the Caenorhabditis elegans dauer formation pathway.
  Inoue T, Thomas JH. Inoue T, et al. Genetics. 2000 Nov;156(3):1035-46. doi: 10.1093/genetics/156.3.1035. Genetics. 2000. PMID: 11063683 Free PMC article.
• Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans.
  Wang YA, Kammenga JE, Harvey SC. Wang YA, et al. Hum Genomics. 2017 May 25;11(1):12. doi: 10.1186/s40246-017-0108-4. Hum Genomics. 2017. PMID: 28545550 Free PMC article. Review.
• Aging: past, present and future.
  Blagosklonny MV, Campisi J, Sinclair DA. Blagosklonny MV, et al. Aging (Albany NY). 2009 Jan 7;1(1):1-5. doi: 10.18632/aging.100009. Aging (Albany NY). 2009. PMID: 20157590 Free PMC article. No abstract available.
• ROP-1, an RNA quality-control pathway component, affects Caenorhabditis elegans dauer formation.
  Labbé JC, Burgess J, Rokeach LA, Hekimi S. Labbé JC, et al. Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13233-8. doi: 10.1073/pnas.230284297. Proc Natl Acad Sci U S A. 2000. PMID: 11069285 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal